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Abstract
Introduction: Empirical research on the burden and determinants of common mental disorders (CMDs), especially depression
and anxiety, among older adults living with HIV (OALWH) in sub-Saharan Africa is inadequate. To bridge the gap in Kenya we:
(1) determined the prevalence of CMDs among OALWH on routine HIV care compared to HIV-negative peers; (2) investigated HIV status as an independent predictor of CMDs in older adults; and (3) investigated CMD determinants.
Methods: In a cross-sectional study conducted between 2020 and 2021, the prevalence of CMDs and associated determinants were investigated at the Kenyan coast among 440 adults aged ≥50 years (257 OALWH). The Patient Health Questionnaire and Generalized Anxiety Disorder scale were administered alongside measures capturing biopsychosocial information.
Logistic regression was used to examine the correlates of CMDs.
Results: No significant differences were found in the prevalence of mild depressive symptoms, 23.8% versus 18.2% (p = 0.16)
and mild anxiety symptoms, 11.7% versus 7.2% (p = 0.12) among OALWH compared to HIV-negative peers, respectively. HIV
status was not independently predictive of CMDs. Among OALWH, higher perceived HIV-related stigma, ageism, increasing
household HIV burden, loneliness, increasing functional disability, sleeping difficulties, chronic fatigue and advanced age (>70
years) were associated with elevated CMDs. Among HIV-negative older adults, loneliness, increased medication burden and
sleeping difficulties were associated with elevated depressive symptoms. Easier access to HIV care was the only factor associated with lower CMDs among OALWH.
Conclusions: On the Kenyan coast, the burden of moderate and severe CMDs among older adults is low; however, both
OALWH and their HIV-negative peers have a similar relatively high burden of mild depressive and anxiety symptoms. Our
results also suggest that determinants of CMDs among OALWH in this setting are predominantly psychosocial factors. These
results highlight the need for psychosocial interventions (at the family, community and clinical levels) to mitigate the risks of
mild CMDs as they are known to be potentially debilitating.
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1

INTRODUCTION

Common mental disorders (CMDs), especially depression and
anxiety, are among the leading causes of disability worldwide
[1, 2] and cost the global economy about US$1.2 trillion a
year [3]. Notably, the global burden of both disorders has
not reduced since 1990, despite compelling evidence of costeffective interventions [4]. Efforts to address this substantial
burden of CMDs should be directed at the most vulnerable in

society, including older adults living with HIV (OALWH) residing in sub-Saharan Africa (SSA). In Kenya, the increasing population of OALWH [5] is experiencing an elevated incidence of
chronic age-related conditions [6], all potentially resulting in
an increase of CMDs.
The prevalence of depression among OALWH in SSA ranges
from 6% to 59% [7] compared to 26% among their HIVnegative peers [8]. Outside SSA, estimates of depression
among OALWH range from 19% to 45% in Asia [9, 10], 39%
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to 90% in the United States [11, 12], 16% to 35% in Latin
America and the Caribbean [13], and 28% in Europe [14].
Anxiety, on the other hand, ranges from 3% to 21% among
OALWH in SSA [7] and 35% to 56% in high-income countries
(HICs) [14, 15].
Understanding the determinants of CMDs among older
adults is critical in designing and implementing contextually
relevant mental health interventions. A recent review indicated that frequently reported determinants of depression
among OALWH were mainly socio-demographic in nature [7].
Among psychosocial factors, HIV-related stigma [16], HIV status disclosure [16] and increasing disability scores have been
associated with higher odds of depressive symptoms, while
social support [17], resilience [16] and spirituality [17] have
been shown to be protective factors. Biomedical and lifestyle
factors, including alcohol use [17], current/former tobacco
smoking [18] and back pain [19], have been associated with
elevated levels of depression among OALWH. Among HIVnegative older adults in SSA, rural residence [20, 21], poor
social network [20], living alone [22], being female [8, 20] and
a lifetime of unskilled occupation [21] have been associated
with elevated odds of depression. No study in SSA has examined the determinants of anxiety among OALWH.
Several reasons call for investigating depression and anxiety among older adults. Firstly, known risk factors for CMD,
such as poverty, are more prevalent in older ages [23, 24].
Secondly, CMDs in late life are severely under-researched and
underdiagnosed in primary care [7, 25]. Besides, the prognosis of CMDs among old adults appears to be worse than for
young people [26]. Late-life CMDs may also elevate the risk
of developing dementia [27]. Among people living with HIV
(PLWH), depression and anxiety have been associated with
non-adherence to combination antiretroviral therapy (cART),
risky sexual behaviours, reduced quality of life and higher suicide rates [28–30]. Given that CMDs are rarely detected but
can have serious health impacts on older people, it is increasingly important to assess for mild, moderate and severe levels
to determine the scale of the problem [31].
To bridge the gap in Kenya, our study seeks to: (1) determine the prevalence of depressive and anxiety symptoms
among OALWH compared to their HIV-negative peers; (2)
investigate HIV status as an independent predictor of depressive and anxiety symptoms in the older adults; and (3) investigate the determinants of CMDs among older adults at the
coast of Kenya.

2

METHODS

2.1

Study design and setting

This cross-sectional study was conducted at the Kenyan coast
in Kilifi and Mombasa Counties between February 2020
and October 2021. The majority of Kilifi residents are rural
dwellers whose main form of livelihood is subsistence farming and small-scale trading [32]. Kilifi has an adult HIV prevalence of 4.5% [33]. Mombasa County borders Kilifi County
to the north and is considered urban. The common sources
of income in Mombasa county include tourism, wholesale and
retail trade. The Mombasa adult HIV prevalence is 7.5% [33].
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2.2
2.2.1

Study participants and recruitment
Older adults living with HIV

OALWH were recruited from two public HIV specialized clinics in Kilifi and Mombasa Counties. As inclusion criteria, participants had to be aged ≥50 years of age, with a confirmed
HIV seropositivity status, and on cART.
In both facilities, we were assisted by community health
volunteers or healthcare providers in reviewing existing
records to identify all potential participants. We used systematic sampling to identify potential clients for the study.

2.2.2

Older adults without HIV

All HIV-negative older adults were recruited in Kilifi County.
The Kilifi Health and Demographic Surveillance System was
used to identify families with eligible older adults. Potential participants aged ≥50 were randomly identified from the
existing database and followed up at their homes using GPS
coordinates. To be included in the study, individuals had to be
≥50 years, and residents of Kilifi county, and provide consent
for participation, including willingness to be tested for HIV
using a rapid HIV testing kit (OraQuick) for a confirmation of
HIV-negative status. We chose HIV-negative adults aged ≥50
years as our comparison group to the OALWH based on previous research [34, 35].

2.3

Sample size calculations

Our sample size was calculated using previous studies from
Uganda [36] and South Africa [35]. An overall sample size of
at least 372 individuals was needed to detect a difference in
CMDs between OALWH and HIV-negative community controls at 80% power and a 5% level of statistical significance.
A sample of 450 participants was considered sufficient, allowing for missing data.

2.4

Measures

The research instruments were programmed on android
tablets using the Research Electronic Data Capture (REDCap) platform [37] for face-to-face interviewer administration.
All research assistants were trained for 2 weeks by the first
author prior to data collection.

2.4.1

Socio-demographic and asset index form

Socio-demographic information was captured in REDCap. We
also collected information on individual and family ownership
of disposable assets for asset index computation. Participants
were also asked to provide information on their access to
social support, food security in the past week, the number of
PLWH within the household and whether they were caring for
a sick family member.

2.4.2

General health form

We captured the participant’s anthropometric details. Other
information included hours spent on sedentary activities in a
day, sexual activity, household HIV burden, number of medications one used and common somatic complaints.
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Among OALWH, HIV-specific information questions were
asked relating to the disclosure of HIV status and access to
HIV care. Information regarding their current cART regimen
and overall duration on cART was extracted from medical
records. Blood samples were also collected from OALWH for
viral load testing.

2.4.3

Psychosocial measures

The brief 12-item HIV stigma scale [38] was utilized to assess
participants’ perceived HIV-related stigma. Higher scores indicate a greater level of perceived stigma. In the current study,
this scale yielded good internal consistency alpha, 0.78 (95%
CI 0.73, 0.83).
The 12-item World Health Organization Disability Assessment
Schedule 2 (WHODAS 2) [39] was used to assess for functional
disability among participants. Higher scores indicate a greater
level of disability. In this study, the tool demonstrated good
internal consistency alpha, 0.77 (95% CI 0.70, 0.84).
The UCLA 8-item loneliness scale [40] was used to assess
participants’ perceived loneliness. Higher scores equate to a
greater level of loneliness. In the present study, this scale
had acceptable internal consistency alpha, 0.61 (95% CI 0.56,
0.64).
The 20-item Ageism survey [41] was used to assess participants’ experiences of ageism. Higher scores indicate more frequent experiences of ageism. In the current study, the internal
reliability (Cronbach’s alpha) was 0.89 (95% CI 0.87, 0.92).

2.4.4

Measures of common mental disorders

The 7-item Generalized Anxiety Disorder scale (GAD-7) [42]
and the 9-item Patient Health Questionnaire (PHQ-9) [43]
were utilized to measure anxiety and depressive symptoms
in the previous 2-week period, respectively. The total scores
range from 0 to 21 for GAD-7 and 0 to 27 for PHQ-9.
For GAD-7, total scores of 5–9, 10–14 and 15–21 represent mild, moderate and severe anxiety symptoms, respectively [44]. Total scores of 5–9, 10–14 and 15–27 indicate
mild, moderate and severe depressive symptoms [45], respectively. A cut-off score of ≥5 for both PHQ-9 and GAD-7
was used to define a positive screen for depressive and anxiety symptoms in the current study, similar to previous studies in Ethiopia [46] and Tanzania [47]. In the present study,
the internal consistency alphas for PHQ-9 and GAD-7 were
good, 0.75 (95% CI 0.70, 0.79) and 0.74 (95% CI 0.70, 0.79),
respectively.

prevalence of CMDs among OALWH and their HIV-negative
counterparts. The Chi-square test was utilized to compare
group differences on binary outcome variables. To investigate
HIV status as an independent predictor of CMDs, we utilized logistic regression analyses adjusting for exposure variables that accounted for differences in CMDs. To examine
the correlates of CMDs, we used logistic regression models
to explore univariate relationships between the binary outcome variables and the different exposure variables. Exposure variables with a p-value < 0.15 in the univariate analysis were subsequently entered into the multivariable models
using forward selection (data for OALWH and HIV-negative
older adults were analysed separately for this set of analyses). In all models, collinearity was checked and for all tests
of the hypothesis, a two-tailed p-value < 0.05 was regarded
as statistically significant. The overall fit of the final models
was examined by Hosmer and Lemeshow (HL) goodness of fit
test where a p-value of > 0.05 was considered a good fit. The
HL test results were cross-checked using McFadden’s pseudoR squared statistic.

2.6

Ethics approval and consent to participate

The study was approved by the Kenya Medical
Research Institute Scientific and Ethics Review Unit
(Ref: KEMRI/SERU/CGMR-C/152/3804). Permission to
conduct the study was granted by the research office
Kilifi (Ref: HP/KCHS/VOL.X/171) and Mombasa (Ref:
COH/Msa/RSC/04). All respondents provided written
informed consent for their participation.

3

R E S U LT S

3.1

Sample characteristics

A total of 440 participants were included in this study, with a
mean age of 60.1 (SD = 6.9) years. The participant response
rate was 90%. This included 72 (16%) OALHIV in Mombasa
and 368 (84%) in Kilifi. Most participants had formal education (63.2%), were unemployed (65.5%), lived in multigenerational households (81.6%) and cared for a sick family member
(66.4%). OALWH were likely to be younger, unmarried, more
educated, have lower monthly household income, live alone,
with a smaller number of dependents and more food insecure
(Table 1).

3.2

HIV-related characteristics of OALWH

All study questionnaires not previously adapted to the local
language of Swahili underwent the recommended adaptation
procedure in line with international guidelines [48].

The majority of the OALWH had disclosed their HIV status
(95.3%) and were on first-line cART treatment (90%). The
mean (SD) duration of HIV treatment was 11.4 (4.3) years.
Nearly, all (98.1%) of the OALWH had a viral load of ≤1000
copies/ml (Table 2).

2.5

3.3

2.4.5

Translation of new study measures

Statistical analysis

All analyses were carried out in STATA version 15.0 (StataCorp LP, College Station, TX, USA). Independent Student’s ttest and Chi-square test were used to compare differences
in continuous and categorical independent variables, respectively. We used proportions as percentages to estimate the

Prevalence estimates for CMDs

The prevalence of mild depressive symptoms was 23.8%
among OALWH compared to 18.2% in the comparison group
(p = 0.16). The prevalence of mild anxiety symptoms was
11.7% among OALWH compared to 7.2% in the comparison
group (p = 0.12). The prevalence of comorbid mild depressive

59

Mwangala PN et al. Journal of the International AIDS Society 2022, 25(S4):e25977
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25977/full | https://doi.org/10.1002/jia2.25977

Table 1. Characteristics of the study population by HIV status, N = 440

Total sample
N = 440

HIV status
Older adults
without HIV,
n = 183

50–59
60–69
≥70

227 (51.6)
171 (38.9)
42 (9.5)

84 (45.9)
74 (40.4)
25 (13.7)

143 (55.6)
97 (37.7)
17 (6.6)

0.02

Sex
Female
Male

258 (58.6)
182 (41.4)

98 (53.6)
85 (46.4)

160 (62.3)
97 (37.7)

0.07

Marital status
Never married
Separated/Divorced/Widowed

12 (2.8)
181 (41.1)

4 (2.2)
45 (24.6)

8 (3.1)
136 (52.9)

<0.001†

247 (56.1)

134 (73.2)

113 (44.0)

162 (36.8)

90 (49.2)

72 (28.0)

Primary
Secondary

182 (41.4)
73 (16.6)

65 (35.5)
22 (12.0)

117 (45.5)
51 (19.9)

Tertiary
Employment
Unemployed

23 (5.2)

6 (3.3)

17 (6.6)

Characteristic

Older adults
living with HIV,
n = 257

p-value

Socio-demographic
Age (years)

Married/cohabiting
Education level
None

<0.001†

288 (65.5)

126 (68.9)

162 (63.0)

Employed
Retired
Monthly household income (Ksh)

116 (26.3)
36 (8.2)

39 (21.3)
18 (9.8)

77 (30.0)
18 (7.0)

≤10,000
Above 10,000
Living arrangements

279 (63.4)
161 (36.6)

69 (37.7)
114 (62.3)

210 (81.7)
47 (18.3)

<0.001

359 (81.6)
41 (9.3)
40 (9.1)

169 (92.3)
6 (3.3)
8 (4.4)

190 (73.9)
35 (13.6)
32 (12.5)

<0.001†

3.2 (2.6)

3.6 (2.5)

2.9 (2.7)

0.01

291 (66.4)

104 (57.1)

187 (73.1)

0.001

147 (33.6)

78 (42.9)

69 (26.9)

199 (45.2)

93 (50.8)

106 (41.2)

215 (48.9)
26 (5.9)

83 (45.4)
7 (3.8)

132 (51.4)
19 (7.4)

Food insecurity (lack of food in the past week),
OM = 3
Never

293 (67.1)

134 (73.6)

159 (62.4)

Sometimes
Most of the times/always
Asset index scorea —mean (SD)

119 (27.2)
25 (5.7)
2.3 (1.5)

45 (24.7)
3 (1.7)
1.9 (1.2)

74 (29.0)
22 (8.6)
2.5 (1.6)

Body mass index—mean (SD), OM = 11
Loneliness scoreb —mean (SD), OM = 3
Functional disability scorec —mean (SD), OM = 2

24.9 (6.0)
13.9 (3.7)
2.5 (4.3)

24.7 (6.1)
13.0 (3.4)
1.5 (3.0)

25.0 (5.9)
14.6 (3.7)
3.1 (4.9)

0.7
<0.001
<0.001

4.2 (5.9)
4.5 (2.6)

3.0 (4.4)
4.3 (2.1)

5.0 (6.6)
4.6 (2.9)

<0.001
0.3

Multiple generational families
Single generational families
Alone
Number of dependents, mean (SD)
Caring for a sick family member, OM = 2
Yes
No
Access to instrumental/social support
None
Sometimes
Most of the time

Ageism scored —mean (SD)
Hours spent in sedentary activities in a day, mean
(SD), OM = 12

0.1

0.07

0.002†

<0.001

(Continued)
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Table 1. (Continued)

Characteristic
Sexually active, OM = 4
Yes

Total sample
N = 440

HIV status
Older adults
without HIV,
n = 183

Older adults
living with HIV,
n = 257

206 (47.3)

105 (57.4)

101 (39.9)

No
Sleeping difficulties in the past month, OM = 4
None

230 (52.7)

78 (42.6)

152 (60.1)

276 (63.3)

125 (68.3)

151 (59.7)

Sometimes
Most of the times/always
Chronic fatigue

131 (30.1)
29 (6.6)

53 (29.0)
5 (2.7)

78 (30.8)
24 (9.5)

Yes
No
Number of medications participants are currently

56 (12.7)
384 (87.3)
1.6 (1.6)

21 (11.5)
162 (88.5)
0.4 (1.2)

35 (13.6)
222 (86.4)
2.4 (1.2)

p-value

<0.001

0.01†

0.5
<0.001

using, mean (SD), OM = 8
Note: All numbers are reported as frequencies with percentages unless otherwise stated. p-values are for the difference between OALWH and
their HIV-negative peers by sample characteristic. p-values have been derived from Chi-square test (or Fisher’s exact test) and independent
Student’s t-test for categorical and continuous independent variables, respectively.
Abbreviations: Ksh, Kenya shillings; OM, observation with missing value; SD, standard deviation.
a Score range = 0–8, higher scores indicate better socio-economic status.
b Score range = 8–27, higher scores indicate greater loneliness.
c Score range = 0–33, higher scores indicate increasing disability.
d Score range = 0–34, higher scores indicate increasing ageism.
† Based on Fisher’s exact test.

and anxiety symptoms among OALWH was 10.1% compared
to 4.4% in the comparison group (p = 0.03) (Table 3).

3.4

Association between HIV status and CMDs

In univariate and multivariate logistic regression analyses, HIV
seropositivity was not significantly associated with depressive
or anxiety symptoms (Table 4). However, HIV seropositivity
was significantly associated with higher odds of a positive
screen for depressive and anxiety symptoms co-occurrence in
univariate but not in the multivariate model.

3.5

nificantly associated with higher odds of anxiety symptoms
among OALWH.

3.5.3

Comorbid depressive and anxiety symptoms

In the multivariable analyses, perceived functional disability
and ageism were significantly associated with higher odds
of comorbid depressive and anxiety symptoms. Easier access
to HIV care was significantly associated with lower odds of
comorbid depressive and anxiety symptoms.

Determinants of CMDs in OALWH

Table 5 presents results from logistic regression analyses
exploring the determinants of CMDs among OALWH.

3.5.1

Depressive symptoms

In the multivariable logistic regression model, factors significantly associated with higher odds of depressive symptoms
among OALWH were functional disability, ageism, sleeping difficulties, chronic fatigue, increasing household HIV burden and
perceived HIV-related stigma. Easier access to HIV care was
significantly associated with lower odds of depressive symptoms.

3.5.2

Anxiety symptoms

In the multivariable analyses, age ≥70, perceived loneliness,
functional disability, ageism and sleeping difficulties were sig-

3.6
Determinants of CMDs in HIV-negative older
adults
The current work largely focused on OALWH. As such, we
only provide a summary of the factors associated with CMDs
among the HIV-negative older adults using the available data,
particularly focusing on mild depressive symptoms whose
prevalence was relatively high in the current sample, that
is >10%. In multivariable analyses (Table S1), sleeping difficulties, perceived loneliness and increasing medication burden were significantly associated with higher odds of a positive screen for depressive symptoms among HIV-negative
older adults. Greater sedentary behaviour and higher monthly
household income were significantly associated with lower
odds of depressive symptoms.
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Table 2. HIV-related clinical and psychosocial characteristics
of OALWH, n = 257
Mean (SD) or
Characteristic

frequency (%)

HIV status disclosure
Yes
No
Household HIV burden, mean (SD); OM = 5

245 (95.3%)
12 (4.7%)
1.4 (1.6)

cART regimen
First line
Second line

233 (90.7%)
23 (8.9%)

Third line
cART regimen change/interruption since HIV
diagnosis

1 (0.4%)

Yes
No
Duration on cART (years), mean (SD), OM = 10

110 (42.8%)
147 (57.2%)
11.4 (4.3)

Viral suppression, OM = 45
Yes

208 (98.1%)

No
Access to HIV care, OM = 4
Easily accessible
Not easily accessible
Perceived HIV-stigma score, OM = 1
Personalized stigmaa —mean (SD)
Disclosure concernsb —mean (SD)
Concerns about public attitudesc —mean (SD)
Negative self-imaged —mean (SD)
Overall stigmae —mean (SD)

4 (1.9%)
169 (66.8%)
84 (33.2%)
5.0 (1.9)
8.6 (2.0)
7.6 (2.2)
6.4 (2.1)
27.5 (5.4)

Abbreviations: cART, combination antiretroviral therapy; OM, observation with missing value; OALWH, older adults living with HIV.
a Score range = 3–12, higher scores indicate greater stigma.
b Score range = 3–12, higher scores indicate greater stigma.
c Score range = 3–12, higher scores indicate greater stigma.
d Score range = 3–12, higher scores indicate greater stigma.
e Score range = 12–44, higher scores indicate greater stigma.

4

DISCUSSION

To our knowledge, this is the first study in Kenya and
among the first reports from SSA investigating CMDs among
OALWH compared to their HIV-negative peers. Our study
found a relatively high burden of mild depressive and anxiety symptoms; however, HIV status was not independently
associated with these symptoms. The correlates of CMDs in
our study were predominantly psychosocial factors, many of
which are potentially modifiable, thus highlighting the need to
address the psychosocial needs of these adults alongside their
biomedical needs.
Our finding of no significant differences in the prevalence
of CMDs between OALWH and their HIV-negative peers is
dissimilar to other emerging reports in SSA. In rural Uganda,
OALWH on cART had a significantly lower prevalence of
probable depression than their HIV-negative peers [36], similar to what was reported in rural South Africa [35]. Our
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finding also offers an interesting contrast to the predominant
findings in HICs showing that OALWH present with worse
CMDs than their HIV-negative peers [24]. The observed variation could reflect contextual differences across settings, for
example healthcare systems, informal support systems and
mental health resources that are likely to alter the risk profile of these adults. HIV status was not found to be an independent predictor of CMDs in our study. This observation
is consistent with previous findings from South Africa [49]
and Uganda [19] but contrasts with common research findings in HICs [24]. Our study may be part of an emerging body
of evidence in SSA showing that the psychological health of
OALWH is not worse than among those without HIV.
HIV-related stigma was significantly associated with higher
odds of depressive symptoms among OALWH in our study.
These findings are consistent with previous findings in the
literature [12, 16, 50] and provide additional evidence of
the critical role of addressing intersecting stigma in improving the mental wellbeing of OALWH. Relatedly, ageism was
also significantly associated with higher odds of depressive
symptoms, anxiety symptoms and their co-occurrence among
OALWH. This finding is consistent with previous research
conducted outside SSA [51]. Ageism could have an adverse
impact on the mental health of OALWH through psychological, behavioural and physiological pathways [52]. Interventions
addressing both ageist and HIV-stigmatizing attitudes at the
community level will potentially improve the mental health of
OALWH.
Increasing household HIV burden was significantly associated with higher odds of depressive symptoms among
OALWH in our study. This may be related to the high caregiving burden often experienced by OALWH caring for HIVpositive children. This observation concurs with previous findings in the study setting [53].
Loneliness is common among older adults in general [54]. In
this study, higher perceived loneliness was significantly associated with elevated odds of anxiety symptoms among OALWH
and depressive symptoms among HIV-negative older adults.
Our finding is consistent with previous studies from HICs
[12, 55]. Theoretical models suggest that loneliness has cognitive, biological and social consequences that could potentially heighten the risk of subsequent CMDs [56]. Higher
perceived functional disability was also strongly associated
with higher odds of depressive symptoms, anxiety symptoms
and their co-occurrence among OALWH in the current study,
consistent with previous findings [19, 57, 58]. Since functional disability occurs frequently among OALWH, there is
a need for early identification to help preserve functional
independence.
Sleep disturbance is a prominent symptom in people with
CMDs, especially depression, and was formerly regarded as
a main secondary indicator of depression [59]. Nonetheless,
multiple prospective studies have identified insomnia as an
independent risk indicator for emerging or recurrent depression, suggesting that sleep problems are not necessarily secondary effects of CMDs but a predictive prodromal symptom
[60, 61]. In this study, persistent sleep problems were significantly associated with higher odds of depressive symptoms,
anxiety symptoms and their co-occurrence among OALWH
and higher odds of depressive symptoms among HIV-negative
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Table 3. Prevalence of common mental disorders in OALWH versus their HIV-negative peers
Older adults without HIV, n = 181
Prevalence
Number
(95% CI)
Severity of depressive symptoms
Mild
Moderate

28
5

Older adults living with HIV, n = 256
Prevalence
Number
(95% CI)

0.3†

49
8

19.1 (14.5, 24.5)
3.1 (1.4, 6.1)

4

1.6 (0.4, 4.0)

18.2 (12.9, 24.6)

61

23.8 (18.7, 29.5)

0.2

7.2 (3.9, 12.0)
–

26
4

10.2 (6.7, 14.5)
1.6 (0.4, 4.0)

0.1†

Positive anxiety symptoms screen (cut-off ≥5)
Yes
13
7.2 (3.9, 12.0)
Positive screen for comorbid depressive and anxiety symptoms

30

11.7 (8.0, 16.3)

0.1

26

10.1 (6.7, 14.5)

0.03

Severe
–
Positive depressive symptoms screen (cut-off ≥5)
Yes
33
Severity of anxiety symptoms
Mild
Moderate

Yes

13
–

8

15.5 (10.5, 21.6)
2.8 (0.9, 6.3)

p-value

–

4.4 (1.9, 8.4)

Abbreviation: 95% CI, 95% confidence interval; OALWH, older adults living with HIV.
† Based on Fisher’s exact test.

older adults. This finding is consistent with previous findings [59, 62, 63]. A combination of pharmacological and
non-pharmacological interventions for sleep disturbances may
effectively reduce and possibly prevent CMDs [64].
Chronic fatigue was also significantly associated with
increased odds of depressive symptoms among OALWH in
our study, similar to what has been reported elsewhere [65,
66]. Fatigue is a vital indicator of ageing-related declines in
health and functioning [67]. Fatigue management strategies,
such as adequate rest and sleep, are likely to improve the
mental health of OALWH. Among HIV-negative older adults,
an increased medication burden was also significantly associated with higher odds of depressive symptoms, consistent
with previous findings [68]. While the exact mechanism for
this association is unknown, we know that the use of medication increases as the number of medical conditions rises. Multiple medications, which are easily detected by clinicians, can
provide an important clue to healthcare providers to further
investigate depression in their clients.
Among socio-demographic factors, old age (≥70 years) was
significantly associated with higher odds of anxiety symptoms
in OALWH, while higher monthly household income was significantly associated with lower depressive symptoms among
HIV-negative older adults. Mixed findings have been reported
on these factors previously [69].
Easier access to HIV care was the only protective indicator
for CMDs in OALWH in the current study. Given that many
OALWH in Kenya face unique challenges with seeking HIV
care services [70], programmes aimed at strengthening HIV
care access or financial support have the potential to improve
OALWHs’ mental wellbeing. Further decentralizing HIV care
into the community possibly utilizing community health workers may also be beneficial.
Among HIV-negative older adults, an increasing number of
hours on sedentary activities was significantly associated with
lower odds of depressive symptoms. More studies are needed

to better understand the mechanism involved. Emerging data
suggest that passive sedentary behaviours, for example television watching, increase the risk of depression, while mentally
active sedentary behaviours, for example reading, may be protective against depression [71].
Most of our data (about 84%) were collected after
the onset of the COVID-19 pandemic. Some studies have
reported elevated levels of loneliness, depression, anxiety
and insomnia among older adults following the outbreak of
COVID-19 [72–74], while others have reported no changes
before and during the pandemic despite increased loneliness
during the pandemic [75]. Other studies have shown that
younger populations have had higher rates of CMDs compared to older adults [76–79]. While it is possible that the
emergence of the pandemic may have created an environment where the determinants of poor mental health could
have been exacerbated, our study found low prevalences
of CMDs, similar to previous research, suggesting higher
resilience to the mental health effects of COVID-19 [80].
The long-term impacts of the pandemic remain unclear, especially in SSA where data on older adults’ mental health are
very scarce. More studies are needed to elucidate these
findings.
The strengths of the current study include the focus on a
neglected but rapidly growing population of OALWH, the use
of a comparison group and sufficient sample size. Nonetheless, the cross-sectional nature of the study precludes any
conclusion on causality. We recruited our OALWH from public
HIV clinics, as such, our findings may not be readily generalizable to OALWH who may be out of care or attending private
or urban HIV clinics or recruited from the community. We
also utilized self-report screening measures which could be
subject to reporting bias. Relatedly, the mental health screening measures do not give a clinical diagnosis of the studied
CMDs, hence, we only report the symptomatology of these
conditions.
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Table 4. Association between HIV status and common mental disorders across the whole sample of older adults

Covariate

Positive screen for depressive
symptoms
Crude
analysis
Adjusted analysis

Positive screen for anxiety
symptoms
Crude analysis

Adjusted analysis

Comorbid depressive and anxiety
symptoms
Crude
analysis
Adjusted analysis

OR (95% CI)

aOR (95% CI)

OR (95% CI)

aOR (95% CI)

OR (95% CI)

aOR (95% CI)

Ref
1.40 (0.87,
2.25)

Ref
0.54 (0.27, 1.07)

Ref
1.72 (0.87,
3.39)

Ref
0.46 (0.18, 1.19)

Ref
2.46* (1.09,
5.57)

Ref
0.74 (0.25, 2.22)

HIV status
Seronegative
Seropositive
Sex
Male
Female

Ref
1.68 (0.84, 3.38)

Ref
2.49 (0.95, 6.54)

Ref
1.93 (0.67, 5.56)

Age (years)
50–59
60–69

Ref
0.89 (0.46, 1.70)

Ref
1.78 (0.71, 4.47)

Ref
1.72 (0.59, 4.98)

0.56 (0.19, 1.69)

3.99* (1.08, 14.71)

3.94 (0.92, 16.94)

Above 70
Marital status
Never married

Ref

Ref

Ref

0.14* (0.03, 0.69)

0.40 (0.06, 2.75)

0.83 (0.06, 11.27)

Married/cohabiting
Asset Index score
Sexually active

0.12* (0.02, 0.62)
0.77* (0.60, 0.98)

0.48 (0.07, 3.53)
1.06 (0.77, 1.46)

1.26 (0.09, 18.17)
0.91 (0.63, 1.32)

No
Yes
Functional disability score

Ref
2.61* (1.24, 5.47)
1.18** (1.09, 1.28)

Ref
0.96 (0.38, 2.43)
1.14* (1.05, 1.24)

Ref
0.81 (0.28, 2.29)
1.14* (1.04, 1.24)

Loneliness score
Ageism score
Caring for a sick family

1.12* (1.03, 1.22)
1.10** (1.04, 1.16)
2.08* (1.08, 4.02)

1.16* (1.04, 1.30)
1.16** (1.08, 1.24)
3.50* (1.32, 9.28)

1.12 (0.99, 1.27)
1.16** (1.08, 1.25)
3.07* (1.03, 9.20)

member
Chronic fatigue
Sleeping difficulties for the

3.14** (1.46, 6.72)

1.80 (0.69, 4.67)

1.86 (0.66, 5.24)

Ref
4.62** (2.38, 8.98)

Ref
3.64* (1.47, 9.03)

Ref
4.69* (1.59, 13.88)

10.89** (3.57,
33.24)
431

4.89* (1.35, 17.63)

7.30* (1.76, 30.27)

431

431

Hosmer–Lemeshow test

X2 = 433.90;
p = 0.25

X2 = 307.20;
p = 0.99

X2 = 338.67;
p = 0.99

Variance explained

35.0%

36.4%

38.8%

Separated/Divorced/
Widowed

past month
None
Sometimes
Most of the time/always
Number of the final model

Abbreviations: aOR, adjusted odds ratio; CMD, common mental disorder; GAD, generalized anxiety disorder; OR, odds ratio; Ref, reference
group.
*p-value < 0.05, **p-value < 0.001.

Despite the outlined limitations, this study has important
implications for the care of older adults in our setting. We
observed substantial levels of mild depressive and anxiety
symptoms in both OALWH and their HIV-negative peers,
highlighting the need for culturally appropriate mental health
interventions in these older adults, regardless of their HIV
status. Routine screening for CMDs should be strengthened to identify those at risk. Risk indicators for depressive
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symptoms, anxiety symptoms and their co-occurrence in
this study were predominantly psychosocial factors. Unfortunately, there is a paucity of research on psychosocial
interventions among OALWH [81] and those in the general
population [82], especially in SSA. Our findings highlight
the need to strengthen the evidence base for interventions
for CMDs among older adults in low-resource settings like
Kenya.
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Table 5. Univariate and multivariable analysis of correlates of common mental disorders among OALWH

Covariate

Positive screen for depressive
symptoms
Univariate
Multivariable
analysis OR
analysis aOR

Positive screen for anxiety
symptoms
Univariate
Multivariable
analysis OR
analysis aOR

Comorbid depressive and anxiety
symptoms
Univariate
Multivariable
analysis OR
analysis aOR

(95% CI)

(95% CI)

(95% CI)

(95% CI)

(95% CI)

(95% CI)

Ref
0.77 (0.41, 1.44)
1.35 (0.44, 4.15)

Ref
0.55 (0.23, 1.32)
1.00 (0.19, 5.24)

Ref
1.18 (0.51, 2.72)
4.19** (1.27,

Ref
2.03 (0.66, 6.20)
7.43** (1.25,

Ref
1.12 (0.45, 2.76)
4.55** (1.37,

Ref
0.73 (0.19, 2.84)
4.76 (0.70,

Age (years)
50–59
60–69
≥70

13.80)
Sex
Male

44.36)

15.09)

32.55)

Ref

Ref

Ref

Ref

Ref

Ref

1.34 (0.73, 2.45)

1.36 (0.58, 3.19)

1.79 (0.76, 4.19)

2.17 (0.58, 8.08)

1.73 (0.70, 4.29)

2.59 (0.64,
10.45)

Never married
Separated/Divorced/
Widowed

Ref
0.19** (0.04,
0.82)

–
–

–
–

–
–

–
–

–
–

Married/cohabiting

0.16** (0.04,
0.73)

–

–

–

–

–

Education level
None
Primary

Ref
0.80 (0.41, 1.57)

–
–

Ref
0.51* (0.22,

–
–

Ref
0.52* (0.22,

–
–

Secondary

0.78 (0.34, 1.80)

–

1.19)
0.38* (0.11,
1.24)

–

1.25)
0.20** (0.04,
0.96)

–

Tertiary

0.16* (0.02,
1.28)

–

0.28 (0.03, 2.30)

–

0.31 (0.04, 2.59)

–

Ref
0.33*** (0.12,

–
–

Ref
0.13* (0.02,

–
–

0.16* (0.02,

–

Female
Marital status

Monthly household
income (Ksh)
≤10,000
Above 10,000

0.86)
Living arrangements
Multiple generational

1.02)

1.22)

–

–

–

–

Ref

–

families
Single generational
families

–

–

–

–

2.11* (0.77,
5.78)

–

Alone
Number of dependents,

–
–

–
–

–
0.87* (0.74,

–
–

1.05 (0.29, 3.82)
–

–
–

mean (SD)
Caring for a sick family
member
No
Yes
Food insecurity (lack of
food in the past week)
Never
Sometimes

1.04)

Ref
0.63* (0.33,
1.16)

–

–

–

–

–

–

–

–

–

–

Ref

–

Ref

–

–

4.21*** (1.75,
10.14)

–

5.95*** (2.18,
16.20)

–

Ref
2.92*** (1.55,
5.49)

(Continued)
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Table 5. (Continued)

Covariate
Most of the

Positive screen for depressive
symptoms
Univariate
Multivariable
analysis OR
analysis aOR

Positive screen for anxiety
symptoms
Univariate
Multivariable
analysis OR
analysis aOR

Comorbid depressive and anxiety
symptoms
Univariate
Multivariable
analysis OR
analysis aOR

(95% CI)

(95% CI)

(95% CI)

(95% CI)

(95% CI)

(95% CI)

2.9** (1.11,

–

6.21** (1.96,

–

–

9.56*** (2.76,

19.70)
1.29*** (1.16,
1.43)

1.16** (1.01,
1.34)

33.15)
1.28*** (1.15,
1.42)

1.19*** (1.10,
1.28)
1.17*** (1.10,

1.10** (1.01,
1.20)
1.14*** (1.06,

1.18*** (1.10,
1.27)
1.17*** (1.11,

1.12** (1.03,
1.22)
1.23*** (1.13,

1.24)
1.13* (1.00,
1.28)

–

times/always
Loneliness score, mean
(SD)

7.62)
1.21*** (1.12,
1.32)

Functional disability
score, mean (SD)
Ageism score, mean (SD)

1.25*** (1.15,
1.35)
1.14*** (1.08,

Hours spent in sedentary
behaviours in a day,

–

–

–

–

–
–

–
–

Ref
0.44* (0.18,
1.06)

–
–

Ref
0.44* (0.17,
1.15)

–
–

1.15** (1.04,
1.28)
1.10** (1.04,

1.19)

1.17)

1.24)

1.23)

1.33)

mean (SD)
Sexually active
No
Yes
Sleeping difficulties in the
past month
None
Sometimes
Most of the
times/always
Chronic fatigue
No
Yes
Number of medications

Ref

Ref

Ref

Ref

Ref

–

6.59*** (3.18,
13.66)
25.60*** (9.00,

3.51** (1.38,
8.89)
8.82*** (2.33,

10.17*** (3.29,
31.47)
18.25*** (4.94,

6.41** (1.73,
23.83)
6.18** (1.26,

11.75*** (3.28,
42.0)
20.31*** (4.80,

–

72.99)

33.37)

67.40)

30.22)

Ref

Ref

Ref

–

Ref

–

7.90*** (3.66,
17.02)
–

5.41** (1.78,
16.38)
–

2.68** (1.09,
6.62)
–

–

3.36** (1.33,
8.46)
1.24* (0.94,

–

–

No
Household HIV burden,

Ref

–

–

–

–

–

2.40* (0.73,
7.85)
1.30** (1.09,

–

–

–

–

–

–

1.21* (0.98,

mean (SD)
cART regimen
change/interruption
since HIV diagnosis
No
Yes

1.37** (1.08,

1.55)

–
–

1.74)

–
–

1.20* (0.98,
1.47)

Ref
2.13* (0.97,

Easily accessible

–

1.49)

–
–

4.68)
Access to HIV care
Not easily accessible

–

1.64)

participants are
currently using, mean
(SD)
HIV status disclosure
Yes

–

85.96)

Ref
1.88* (0.82,

–
–

4.34)

Ref

Ref

Ref

–

Ref

Ref

0.47** (0.26,
0.85)

0.35** (0.15,
0.83)

0.36** (0.16,
0.78)

–

0.29** (0.12,
0.68)

0.16** (0.04,
0.60)
(Continued)
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Table 5. (Continued)
Positive screen for depressive
symptoms
Univariate
Multivariable
analysis OR
analysis aOR

Positive screen for anxiety
symptoms
Univariate
Multivariable
analysis OR
analysis aOR

Comorbid depressive and anxiety
symptoms
Univariate
Multivariable
analysis OR
analysis aOR

(95% CI)

(95% CI)

(95% CI)

(95% CI)

(95% CI)

(95% CI)

1.21** (1.04,
1.41)

1.27** (1.02,
1.59)

1.16* (0.96,
1.42)

–

1.25** (1.02,
1.54)

–

Disclosure concerns
Concerns about public
attitudes

–
1.23** (1.06,
1.42)

–
–

–
1.29** (1.06,
1.57)

–
–

–
1.23** (1.00,
1.51)

–
–

Negative self-image

1.22** (1.06,
1.40)
1.11*** (1.05,

–

1.20** (1.00,
1.44)
1.10** (1.02,

–

1.36** (1.12,
1.66)
1.13** (1.04,

–

Covariate
Perceived HIV-stigma
score, mean (SD)
Personalized stigma

Overall stigma

–

1.18)

–

1.20)

–

1.23)

n for the final model

251

252

245

Variance explained
Hosmer–Lemeshow test

41.7%
X2 = 241.96;
p-value = 0.35

41.0%
X2 = 210.85;
p-value = 0.79

42.0%
X2 = 176.09;
p-value = 0.99

cvMean AUC (95% CI)

0.91 (0.87, 0.96)

0.88 (0.82, 0.95)

0.92 (0.89, 0.96)

Note: Only a priori variables (age and sex), as well as those with p-value < 0.15 in the univariate analysis or multivariable p < 0.05, are presented here. Ten independent variables were fitted for the multivariable model on depressive symptoms, seven variables for both the anxiety
symptoms and CMD comorbidity.
Abbreviations: aOR, adjusted odds ratio; cvMean AUC, cross-validated mean area under the curve for the final multivariable model; OR, odds
ratio; Ref, reference group; OALWH, older adults living with HIV.
*p value < 0.15, **p value < 0.05, ***p value < 0.01.

5

CONCLUSIONS

Ambulatory, out-patient OALWH and their HIV-negative peers
from the community have similar levels of mild depressive
and anxiety symptoms. Additionally, living with HIV is not
predictive of CMDs in this setting. Our study provides an
initial understanding of the determinants of CMDs from a
low-resource setting. Modifiable risk factors, such as ageism,
HIV-related stigma, loneliness, functional disability and sleeping difficulties, represent a target for preventive interventions
through psychosocial interventions at the family, community
and clinical levels.
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S U P P O R T I N G I N F O R M AT I O N
Additional information may be found under the Supporting
Information tab for this article:
Table S1. Univariate and multivariable analysis of the correlates of depressive symptoms among HIV-negative older
adults.
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